Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Current Assets (2016 - 2025)

OptimizeRx's Current Assets history spans 16 years, with the latest figure at $56.3 million for Q3 2025.

  • For Q3 2025, Current Assets rose 20.07% year-over-year to $56.3 million; the TTM value through Sep 2025 reached $56.3 million, up 20.07%, while the annual FY2024 figure was $54.0 million, 0.66% down from the prior year.
  • Current Assets for Q3 2025 was $56.3 million at OptimizeRx, up from $54.1 million in the prior quarter.
  • Across five years, Current Assets topped out at $115.1 million in Q4 2021 and bottomed at $46.0 million in Q2 2024.
  • The 5-year median for Current Assets is $87.4 million (2023), against an average of $80.5 million.
  • The largest annual shift saw Current Assets skyrocketed 297.94% in 2021 before it crashed 49.57% in 2024.
  • A 5-year view of Current Assets shows it stood at $115.1 million in 2021, then fell by 14.37% to $98.6 million in 2022, then plummeted by 44.88% to $54.3 million in 2023, then dropped by 0.66% to $54.0 million in 2024, then rose by 4.35% to $56.3 million in 2025.
  • Per Business Quant, the three most recent readings for OPRX's Current Assets are $56.3 million (Q3 2025), $54.1 million (Q2 2025), and $51.7 million (Q1 2025).